Insider trade

Officer sold ~$1.33M of CRL shares in the open market

Traded Aug 5, 2026 · Filed Aug 6, 2026

~$1.33M
Reported value · 5,046 sh @ $263.00: 4,807
Holds after · shares reported: +10.0%
stock since the trade · S&P 500 -0.8%, $260.72 → $286.83 on Oct 1

Why it stands out

Charles River Laboratories's CEVP, Disc & Safety Assessment sold $1.33M of Charles River Laboratories shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 5, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 6, 2026

Officer$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,327,098

Shares × reported transaction price

Timing vs results

on the day of results (Aug 5, 2026)

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $260.72 on Aug 5, 2026, at its 52-week high, after a 40% rise over the previous 30 trading days

52-week range $145.57 (Sep 25, 2025) to $260.72 (Aug 5, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $186.60 on Jun 23, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred